roles of prostaglandins in acute s, 22 and chronic inflammatory processes 6,11,27 and to discriminate prostaglandin and non-prostaglandin-mediated components of inflammation 4.
A variety of prostaglandins affect various endocrine secretory functions including the endocrine control of sugar homeostasis 39. FSH and LH secretion from rat pituitary is enhanced by PGE2 and PGF2~ 17,z~. The stimulation of gonadotropin release by prostaglandins is explained to be exerted directly on the hypothalamo-pituitary unit as well as mediated by actions on the gonads 9.16. Stimulation of thyroxine release by thyrotropin may be mediated by prostaglandins 26. The possible role of prostaglandins in the regulation of pancreatic endocrine secretion and in the etiology of diabetes mellitus has been investigated. Prostaglandins were first reported to affect insulin secretion in 1968 7. Although evidence implicating prostaglandins as insulin secretagogues is conflicting, the stimulatory effects of administered prostaglandins on glucagon secretion appear to be consistent. In the isolated perfused rat pancreas, reports a0, 31, 32 show that in the presence of glucose (5.6 mmol/1), PGEI PGE_, and PGF2, evoked biphasic release of glucagon and insulin. Recently, we have reported that prostaglandin endoperoxide, PGH2, is a secretagogue for glucagon and insulin (equipotent with the classical prostaglandins, PGE2 and PGF2,) and also that thromboxane (TXA2 and TXB,_) and prostacyclin (PGI2), were not effective secretagogues, whereas PGD2 is a more potent stimulant of glucagon than insulin secretion 5. A comprehensive assessment of the current reported effects of prostaglandins on insulin and glucagon secretion is available in our recent publication 2 and that of ROBERTSON 33. In the present study , isolated pancreata from rats deficient in essential fatty acids were perfused to ascertain the role of prostaglandin precursors in the endocrine pancreas secretory response to insulin and glucagon secretagogues.
MATERIALS AND METHODS
Weanling albino rats of the Sprague-Dawley strain were maintained for 16 weeks on a diet deficient in essential fatty acids (Nutritional Biochemical) and housed under controlled conditions of humidity, light and temperature. Food and water were available ad libitum. Control rats received standard laboratory chow. The principal apparent manifestations of essential fatty acid deficiency were diminished growth rate and scaly dermatitis, mainly on the feet and tail. The animals were anesthetized with sodium pentobarbital (50 mg/kg) injected i.p. and the pancreas with its intact vasculature was removed and transferred to an extracorporeal perfusion apparatus as described previously 3,. The perfusion solution contained 120 mmol/1 NaC1, 4.7 retool/1 KC1, 0.8 mmol/l MgSO4, 2.4 mmol/1 CaC12, 1.2 mmol/1 KH2PO4, 25 mmol/1 NaHCO3, 5.6 mmol/1 D-glucose, 56 ~mol/1 dextran and 30 ~mol/l bovine serum albumin. The perfusion flow rate was kept constant at 2.5 ml/min. Perfusion pressure was monitored continuously using a pressure transducer, an amplifier, and a strip-chart recorder. After a 30-min equilibration period, the experimental protocol was commenced.
The perfusion system employs four independent perfusion channels connecting four corresponding reservoirs which merged into a manifold to which the aortic cannula was connected. With the use of four independent perfusion channels, individual test agents contained in each reservoir can be diverted to perfuse the pancreas via a common aortic cannula. L-arginine monohydrochloride (ICN) (10 mmol/1), L-leucine (Sigma) (10 retool/l) or bovine growth hormone (NIH) (100 ~tmol/l) were dissolved in the basic perfusion medium and added shortly before the experiments to the appropriate reservoir and equilibrated at 37 ~ with a mixture of 95% oxygen and 5% carbon dioxide. Depending on the experimental protocol, rat pancreata were perfused with each secretagogue (with the exception of glucose) for 1 rain, separated by a 15-min period, during which the pancreata were perfused with basic buffer solution only. Perfusion media contained 5.6 mmol/1 glucose at all times. A solution containing 16.7 retool/1 D-glucose was perfused for 30 min. The pancreatic portal venous effluent was collected in l-rain fractions; the samples were chilled immediately, aliquoted for submission to radioimmunoassays, and stored at -20 ~ until the time of assay.
Radioimmunoassays for glucagon and insulin were performed using the 'doubleantibody' method described previously 29. Beef-pork glucagon and rat insulin were used as standards in the respective assays. The 5-min total response areas (where applicable) were computed as described previously 29.34. The amounts of hormone secreted in this time period were derived by multiplying the concentration of each 1-min sample by the flow rate and summing these values for the 5-min interval. The statistical significance of differences between observed values was determined by two-tailed Student's t-test. Values are given as mean -+-SEM.
One-hundred-milligram pieces of tissue, pancreas, liver, heart, lung, kidney and skeletal muscle excised from EFA deficient rats and control rats (pancreas only) were homogenized for 20 sec in chloroform/methanol (2:1, v/v) and acidified with formic acid. The homogenate was heated to 70 ~ for 10 min, cooled and centrifuged. The organic phase was separated and extracted with formic acid according to the procedure of FOLCH et al. 13 and then methylated with 8% concentrated sulfuric acid in methanol. The methyl esters were analyzed by means of gas-liquid chromatography (Varian 3700) on a 10% diethylene glycol succinate (DEGS-PS) glass column at 185 ~ using a flame-ignition detector (FID). Fatty acid esters were identified by use of pure standards. The peak areas were quantified by an automatic digital integrator (Varian). The fatty acid values are expressed as mol % (mean -+-SEM).
RESULTS
Fatty acid levels o/EFA deficient rats -Tab. 1 summarizes data on fatty acid content of pancreata obtained from control rats and EFA deficient rats. These rats were similar to those used in isolated pancreas perfusion to assess hormone release. It can be clearly seen that the level of oleate (18:1, n-9) was significantly lower in the control rats than in the EFA-deficient rats. The increased level of oleate which is a non-essential fatty acid, is probably due to preferential accumulation during essential fatty acid deficiency. Eicosatrienoic acid (20:3, n-9) which like oleate is a non-prostaglandin precursor, was present in trace amounts in control rats, but was significantly elevated in EFA-deficient rats. On the contrary, arachidonic acid (20:4, n-6) and linoleic acid (18:2, n-6) which can serve as substrates for prostaglandin synthesis 3,36 were higher in control rats (15 • 2 and 19 -+-3, respectively) but were present only in trace amounts in EFA-deficient rats (1.6 -+-0.5 and 1.0-----0.4, respectively). Whereas the triene:tetraene (20:3, n-9720:4, n-6) ratio was very low (0.027) as would be expected, this ratio was 8.8 in EFA-deficient rats, which represents approximately 15,000% increase over the control (tab. 1). The high triene:tetraene ratio is indicative of severe EFA deficiency and is comparable to ratios previously reported by other investigators 11,1s,19, 27 In tab. 2 are shown data on fatty acid content of various organs obtained from EFA-deficient rats prior to perfusion of pancreata to ascertain hormone release. As in tab. 1, the levels of non-prostaglandin precursor fatty acids such as 18:1, n-9 and 20:3, n-9 were high in all the organs measured. These values were comparable to those reported in the literature for severely EFA-deficient animals 15. ~9 In contrast, the prostaglandin-precursor fatty acids (20:4, n-6 and 18:2, n-6) were present in trace amounts. The triene:tetraene (20:3, n-9/20:4, n-6) ratios were as follows: liver 3.5 --+---2; skeletal muscle 9.5 • 5; heart 6.9 ----+-5; lung 7.5 ----+-1 and kidney 2.6 • 4. These high ratios are evidence of severe essential fatty acid deficiency and suppressed endogenous prostaglandin synthesis m.13.z7
Glucose-stimulated glucagon and insulin secretion - Fig. 1 illustrates the dynamics of insulin and glucagon secretion in response to an increase in the concentration of glucose from 5.6 to 16.7 mmol/1. The pattern of the insulin secretory response to glucose 16.7 mmol/1 perfused for 30 min was biphasic both in control and EFAdeficient rats. The glucose stimulated acute secretion (phase I) was significantly greater (p<0.01) in magnitude and amplitude in EFA-deficient (open circles) than in the control rats (open squares). There was no significant difference in the second phase of glucose-stimulated insulin secretion between the two groups. There was, however, a slow return to nadir following phase-1 secretion in the EFA-deficient rats. This probably was a normal elution decay in view of the greater amounts of phase-1 insulin in EFA-deficient rats compared to control rats. Glucagon secretion in the control and EFA-deficient rats was inhibited as would be expected by high glucose concentration.
Glucagon and insulin secretion in response to common secretagogues -Tab. 3 summarizes data on glucagon and insulin secretory response to 1-min perfusions of pancreata isolated from EFA-deficient and control rats with L-arginine (10 retool/l), bovine growth hormone (100 ~mol/1) or L-leucine (10 mmol/1). Glucagon secretion in response to arginine was not significantly-different in control and EFAdeficient rats (1, 647 • 591 vs 1,223 -----233, respectively). However, the magnitude of arginine-stimulated insulin release was significantly higher in EFA-deficient than in control rats (5,309 -----863 vs 2,665 +-357) . Growth hormone-induced secretion was variable in the two groups. Whereas bGH-induced gluca~n release was much higher in the control rats, insulin secretion was significantly higher in EFA-deficient rats. Glucagon and insulin secretion in response to L-leucine was minimal but significantly higher than basal secretion (428-----42 vs 49 • 11, glucagon; 233 ---+ 88 vs 60 • 18, insulin). There was no corresponding observation of leucine effect in the control rats.
DISCUSSION
Prostaglandins and related arachidonic acid metabolites are ubiquitous in animal tissues and regulate a variety of biological processes, including hormone secretion. Administered prostaglandins and inhibitors of prostaglandin synthesis modify the secretion of glucagon and insulin, often with conflicting results, as previously reviewed 2,33. The purpose of the present investigation was to determine the effect of suppressed or deprived prostaglandin synthesis upon insulin and glucagon secretion in response to common secretagogues. Data summarized in tabs 1 and 2 convincingly indicate severe EFA deficiency in our animal model. In the pancreas of the EFAdeficient rats, the ratio of trienoic to tetraenoic fatty acids was 8.8. A condition of EFA deficiency in rats with triene/tetraene ratios of 4 or greater has been reported to result in progressive suppression of prostaglandin synthesis 28. Prostaglandin production by platelets obtained from EFA deficient rats was suppressed relative to the degree of EFA-deficiency 28. C~AWrORD et al. 13 have shown that PGEI, PGE2 and PGE2~ content of tissues from EFA-deficient rabbits was significantly lower than in normal rabbits. In these rabbits, there was a corresponding decrease in linoleic and dihomo-y-linolenic acids, fatty acids which are substrates for prostaglandin synthesis. Our fatty acid data presented in tabs 1 and 2 are consistent with those previously reported ,3 glucagon (fmol/5 rain) insulin (fmol/5 rain) agents control rats EFA-deficient rats control rats EFA-deficient rats The high triene/tetraene ratio (8.8) in EFA-deficient rats compared to 0.027 in the controls (tab. 1) indicates that there was little or no arachidonate in the EFA-deficient rats. In corollary, there was no substrate for prostaglandin synthesis, and hence, no potential for any significant synthesis of prostaglandins.
Our results on hormone release illustrated in fig. 1 demonstrate a slightly augmented secretory function of the islets of Langerhans in EFA deficiency. However, the similar pattern and dynamics of glucagon secretion in both the control and EFA-deficient rats suggest a non-mandatory regulatory role of prostaglandins in endocrine pancreas secretion. The enhanced magnitude of phase-1 (acute phase) insulin release induced by glucose in EFA-deficient rats as compared to controls, probably indicates a possible inhibitory effect of prostaglandins 33. As shown in tab. 3, glucagon and insulin secretory response to secretagogues such as bGH and leucine which induce hormone release by mechanism(s) possibly different and unrelated 34 was unaltered by EFA deficiency. There was significantly enhanced argininestimulated insulin secretion in the EFA-deficient rats.
The present observations by no means pose logical contradiction to our previously reported stimulation by exogenously administered prostaglandins in isolated perfused pancreas 2' 29' 3~ However, the mechanism(s) by which administered prostaglandins elicit hormone release could be different and unrelated to the actions of the endogenous prostaglandins. Prostaglandins are a very potent and active class of lipids and could probably modify hormone release in in vitro conditions such as the perfused pancreas without any obligatory regulation of endocrine pancreas secretion.
The mechanism by which administered prostaglandins modulate the secretory activity of endocrine glands is often attributed to interaction of their specific membrane receptors with adenylate cyclase ~0.20, since prostaglandins generally elevate the level of cyclic AMP in tissues and affect metabolic functions regulated by cyclic AMP. The stimulant effect of prostaglandins on endocrine secretion also seems to involve alteration in intracellular calcium concentrations m,20, although HERTELENDY et al. 2, reported that the prostaglandins do not act as ionophores. The pharmacological effects of administered prostaglandins could involve direct action on the cell membrane. MISHIMA and KURIYAMA 18 reported depolarization of guinea pig stomach longitudinal muscle membrane by PGEb PGE2, or PGE2~, suggesting that these prostaglandins may increase calcium influx by stimulating electrical activity of the membrane. Changes in membrane depolarization with the associated calcium influx in response to pancreatic endocrine hormone secretagogues is a well-established phenomenon.
Several reports show that inhibitors of prostaglandin synthesis augment or stimulate secretion of insulin i2.14,24. These observations indicate that endogenous prostaglandins may have an inhibitory role on insulin secretion. Our data in fig." 1" demonstrating an enhanced phase-1 glucose-stimulated insulin secretion in EFAdeficient rat are in agreement with the concept of an inhibitory role of endogenous prostaglandins. MACADAMS et al. 23 observed augmentation of stimulated insulin secretion from isolated perfused pancreas when the donor rats had been pretreated with nictindole (L8027, a combined inhibitor of cyclooxygenase and thromboxane synthase) and indomethacin had been added to the perfusion solutions 37.
We have provided evidence that the secretory function of the endocrine pancreas is operational in EFA deficiency, a condition in which there is deficiency of sub-strates for prostaglandin synthesis. Our studies may exemplify the lack of an obligatory role of prostaglandins in insulin and glucagon secretion. The use of EFA-deficient animals as a model for the study of the role of prostaglandins in endocrine pancreas and other endocrine gland secretions could resolve the conflicting findings concerning the effects of prostaglandins.
